Dune Medical lands FDA approval for breast cancer tissue detector

January 2, 2013 by MassDevice staff

Dune Medical finally wins full FDA pre-market approval for its MarginProbe intra-operative tool for assessing tissue during early-stage breast cancer surgery.

Dune Medical Devices' MarginProbe system

Framingham, Mass.-based Dune Medical Devices finally got the FDA nod for its MarginProbe breast cancer tissue detection system, a device that can help surgeons determine whether they have excised all the cancerous tissue during early-stage breast cancer surgery.

The approval was based on a 664 patient study evaluating the MarginProbe's ability to identify cancerous tissue along the edges of removed breast tissue during early lumpectomy procedures.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.